Intense exposure to light, intense metabolic activity and high oxygen tension render the human eye particularly vulnerable to oxidative damage at all levels from the ocular surface and dry eye, cornea, anterior chamber, crystalline lens and back to the retina, macula and optic nerve. Hence compounds with strong antioxidant capabilities are under the spotlight as a potential treatments to slow eye damage and ageing by reducing the production of reactive oxygen and nitrogen species (ROS and RNS) in the eye.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
